Cargando…

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus

Vaccines are considered one of the greatest advances in modern medicine. The global burden of numerous infectious diseases has been significantly reduced, and in some cases, effectively eradicated through the deployment of specific vaccines. However, efforts to develop effective new vaccines against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudchodkar, Sagar B., Choi, Hyeree, Reuschel, Emma L., Esquivel, Rianne, Jin-Ah Kwon, Jackie, Jeong, Moonsup, Maslow, Joel N., Reed, Charles C., White, Scott, Kim, J. Joseph, Kobinger, Gary P., Tebas, Pablo, Weiner, David B., Muthumani, Kar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Masson SAS on behalf of Institut Pasteur. 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593156/ https://www.ncbi.nlm.nih.gov/pubmed/29555345 http://dx.doi.org/10.1016/j.micinf.2018.03.001

Ejemplares similares

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus
por: Esquivel, Rianne N., et al.
Publicado: (2019)

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
por: Muthumani, K., et al.
Publicado: (2016)

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
por: Maslow, Joel N.
Publicado: (2017)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
por: Modjarrad, Kayvon, et al.
Publicado: (2019)

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Novel suction-based in vivo cutaneous DNA transfection platform
por: Lallow, Emran O., et al.
Publicado: (2021)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease
por: Maslow, Joel N., et al.
Publicado: (2019)

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
por: Patel, Ami, et al.
Publicado: (2018)

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
por: Flingai, Seleeke, et al.
Publicado: (2015)

Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
por: Kim, Woo Joo, et al.
Publicado: (2023)

DNA vaccination protects mice against Zika virus-induced damage to the testes
por: Griffin, Bryan D., et al.
Publicado: (2017)

REDD1 Is Essential for Optimal T Cell Proliferation and Survival
por: Reuschel, Emma L., et al.
Publicado: (2015)

SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
por: Walker, Susanne N., et al.
Publicado: (2020)

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
por: Jiang, Jingjing, et al.
Publicado: (2021)

The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and Emerging Infectious Diseases
por: Tucci, Veronica, et al.
Publicado: (2017)

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2018)

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost
por: Kim, Woo Joo, et al.
Publicado: (2023)

Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus
por: Patel, Ami, et al.
Publicado: (2021)

Zika Virus Vaccines: Challenges and Perspectives
por: das Neves Almeida, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_78cm1q0pcpsso4p6ot2vd1mqjb